1 paper
Elizabeth A. Handorf, J. Robert Beck, Daniel M. Geynisman
Many patients with advanced cancers undergo multiple lines of treatment. We develop methods for estimating quality-adjusted outcomes and cost-effectiveness of therapy sequences, in…